Lack of association between common Polymorphisms in UGT1A9 and gene expression and activity

被引:29
作者
Ramirez, Jacqueline
Liu, Wanqing
Mirkov, Snezana
Desai, Apurva A.
Chen, Peixian
Das, Soma
Innocenti, Federico
Ratain, Mark J.
机构
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Clin Pharmacol & Pharmagenom, Chicago, IL 60637 USA
[4] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
D O I
10.1124/dmd.107.015446
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Interindividual variability in the glucuronidation of xenobiotics metabolized by UDP- glucuronosyltransferase 1A9(UGT1A9) suggests the presence of functional UGT1A9 variants. The aim of this study was to evaluate whether the putative functionality of the UGT1A9 variants -118T(9>10) (rs3832043), 1399C > T (rs2741049), -275T > A (rs6714486), and -2152C > T (rs17868320) could be confirmed in an independent study. UGT1A9 genotypes and UGT1A9 activity (i.e.,flavopiridol and mycophenolic acid glucuronidation) were determined in 46 Caucasian human livers. mRNA levels were quantitated by real-time polymerase chain reaction in 35 of these livers. In addition, samples from 60 unrelated Caucasians belonging to the HapMap Project were also genotyped to confirm the allele frequencies and linkage disequilibrium (LD) pattern observed in our Caucasian livers. The allele frequencies of the -118T(9>10), 1399C > T, -275T > A, and -2152C > T variants were 0.39, 0.39, 0.02, and 0.02 in the livers, respectively. The 1399C > T variant was in complete LD (r(2) = 1) with -118T(9>10) (linked alleles: C and T-9, respectively). Complete LD between these two variants was also found in the HapMap samples (frequencies of -118T(9>10) 10 and 1399C > T = 0.38). 1399C > T and -118T(9>10) correlated with neither UGT1A9 activities nor mRNA levels. Because of the low frequencies of the -275T > A and -2152C > T variants, an effect on phenotype could not be evaluated. Our data demonstrate that the common 1399C > T and -118T(9>10) polymorphisms do not explain interindividual variation in hepatic UGT1A9 activity and mRNA expression and are in complete LD in the donor liver samples we studied.
引用
收藏
页码:2149 / 2153
页数:5
相关论文
共 30 条
[1]   The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes [J].
Albert, C ;
Vallée, M ;
Beaudry, G ;
Bélanger, A ;
Hum, DW .
ENDOCRINOLOGY, 1999, 140 (07) :3292-3302
[2]   Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4α [J].
Barbier, O ;
Girard, H ;
Inoue, Y ;
Duez, H ;
Villeneuve, L ;
Kamiya, A ;
Fruchart, JC ;
Guillemette, C ;
Gonzalez, FJ ;
Staels, B .
MOLECULAR PHARMACOLOGY, 2005, 67 (01) :241-249
[3]   Human UDP-glucuronosyltransferases show atypical metabolism of mycophenolic acid and inhibition by curcumin [J].
Basu, NK ;
Kole, L ;
Kubota, S ;
Owens, IS .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (07) :768-773
[4]   The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants [J].
Bernard, O ;
Guillemette, C .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) :775-778
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases [J].
Court, MH .
PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 :104-116
[7]  
Court MH, 2001, J PHARMACOL EXP THER, V299, P998
[8]   Pharmacogenetics of flavopiridol glucuronidation. [J].
Desai, A ;
Grimsley, C ;
Innocenti, F ;
Kuttob-Boulos, H ;
Ramirez, J ;
Di Rienzo, A ;
Ratain, MJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) :P60-P60
[9]   Variation of hepatic glucuronidation:: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 [J].
Ehmer, U ;
Vogel, A ;
Schütte, JK ;
Krone, B ;
Manns, MP ;
Strassburg, CP .
HEPATOLOGY, 2004, 39 (04) :970-977
[10]   Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver [J].
Girard, H ;
Court, MH ;
Bernard, O ;
Fortier, LC ;
Villeneuve, L ;
Hao, Q ;
Greenblatt, DJ ;
von Moltke, LL ;
Perussed, L ;
Guillemette, C .
PHARMACOGENETICS, 2004, 14 (08) :501-515